{"id":"https://openalex.org/W4392687477","doi":"https://doi.org/10.1158/0008-5472.c.6505341.v1","title":"Data from Cisplatin Resistance Associated with PARP Hyperactivation","display_name":"Data from Cisplatin Resistance Associated with PARP Hyperactivation","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4392687477","doi":"https://doi.org/10.1158/0008-5472.c.6505341.v1"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6505341.v1","doi":"https://doi.org/10.1158/0008-5472.c.6505341.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6505341.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/0008-5472.c.6505341.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001949379","display_name":"Judith Michels","orcid":"https://orcid.org/0000-0002-9640-0222","observed_orcids":["https://orcid.org/0000-0002-9640-0222"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judith Michels","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067656240","display_name":"Ilio Vitale","orcid":"https://orcid.org/0000-0002-5918-1841","observed_orcids":["https://orcid.org/0000-0002-5918-1841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ilio Vitale","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071827163","display_name":"Lorenzo Galluzzi","orcid":"https://orcid.org/0000-0003-2257-8500","observed_orcids":["https://orcid.org/0000-0003-2257-8500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lorenzo Galluzzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006476106","display_name":"Julien Adam","orcid":"https://orcid.org/0000-0001-7556-9101","observed_orcids":["https://orcid.org/0000-0001-7556-9101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julien Adam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033733948","display_name":"Ken Andre\u0301 Olaussen","orcid":"https://orcid.org/0000-0002-3115-8914","observed_orcids":["https://orcid.org/0000-0002-3115-8914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ken Andr\u00e9 Olaussen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056768522","display_name":"Oliver Kepp","orcid":"https://orcid.org/0000-0002-6081-9558","observed_orcids":["https://orcid.org/0000-0002-6081-9558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Kepp","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074355427","display_name":"Laura Senovilla","orcid":"https://orcid.org/0000-0001-6887-2436","observed_orcids":["https://orcid.org/0000-0001-6887-2436"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Senovilla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039220783","display_name":"Ibtissam Talhaoui","orcid":"https://orcid.org/0000-0001-6359-6559","observed_orcids":["https://orcid.org/0000-0001-6359-6559"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ibtissam Talhaoui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028919145","display_name":"Justine Gu\u00e9gan","orcid":"https://orcid.org/0000-0001-6087-5528","observed_orcids":["https://orcid.org/0000-0001-6087-5528","https://orcid.org/0000-0002-1315-6042"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Justine Guegan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088614851","display_name":"David Pierre Enot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Pierre Enot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026360533","display_name":"Monique Talbot","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monique Talbot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088883878","display_name":"Ang\u00e9lique Robin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ang\u00e9lique Robin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006010044","display_name":"Philippe Girard","orcid":"https://orcid.org/0000-0002-1559-8055","observed_orcids":["https://orcid.org/0000-0002-1559-8055"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Girard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109690495","display_name":"C\u00e9dric Or\u00e9ar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C\u00e9dric Or\u00e9ar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080737820","display_name":"Delphine Lissa","orcid":"https://orcid.org/0000-0002-1684-5134","observed_orcids":["https://orcid.org/0000-0002-1684-5134"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Delphine Lissa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026864936","display_name":"Abdul Qader Sukkurwala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdul Qader Sukkurwala","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074719167","display_name":"Pauline Garcia","orcid":"https://orcid.org/0000-0002-4673-8583","observed_orcids":["https://orcid.org/0000-0002-4673-8583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pauline Garcia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022617484","display_name":"Parviz Behnam\u2010Motlagh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Parviz Behnam-Motlagh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113570817","display_name":"Kimitoshi Kohno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimitoshi Kohno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059971077","display_name":"Gen Sheng Wu","orcid":"https://orcid.org/0000-0001-8166-5474","observed_orcids":["https://orcid.org/0000-0001-8166-5474"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gen Sheng Wu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042091947","display_name":"Catherine Brenner","orcid":"https://orcid.org/0000-0002-7715-0934","observed_orcids":["https://orcid.org/0000-0002-7715-0934"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Brenner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067773016","display_name":"Philippe Dessen","orcid":"https://orcid.org/0000-0002-4799-5071","observed_orcids":["https://orcid.org/0000-0002-4799-5071"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philippe Dessen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064506934","display_name":"Murat K. Saparbaev","orcid":"https://orcid.org/0000-0002-4630-1074","observed_orcids":["https://orcid.org/0000-0002-4630-1074"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Murat Saparbaev","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021624793","display_name":"Jean\u2010Charles Soria","orcid":"https://orcid.org/0000-0001-9597-0701","observed_orcids":["https://orcid.org/0000-0001-9597-0701"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Charles Soria","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044366070","display_name":"Maria Castedo","orcid":"https://orcid.org/0000-0001-6855-3451","observed_orcids":["https://orcid.org/0000-0001-6855-3451"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Castedo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5075296559","display_name":"Guido Kroemer","orcid":"https://orcid.org/0000-0002-9334-4405","observed_orcids":["https://orcid.org/0000-0002-9334-4405"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guido Kroemer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10123","display_name":"DNA Repair Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":1.0},{"id":"https://openalex.org/keywords/parp-1","display_name":"PARP1","score":0.9300000071525574},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8180000185966492},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8619999885559082},{"id":"https://openalex.org/keywords/poly-adp-ribosyl-ation","display_name":"poly(ADP-ribosyl)ation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.9610000252723694},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.8360000252723694},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.7160000205039978},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C2778366672","wikidata":"https://www.wikidata.org/wiki/Q5957687","display_name":"Hyperactivation","level":2,"score":0.8879718780517578},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7582687735557556},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.54032963514328},{"id":"https://openalex.org/C57473165","wikidata":"https://www.wikidata.org/wiki/Q7315604","display_name":"Resistance (ecology)","level":2,"score":0.47824540734291077},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3531588912010193},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.34649035334587097},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33010566234588623},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.32359257340431213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3081890344619751},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25946521759033203},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14272278547286987},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.13237181305885315},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.10515081882476807},{"id":"https://openalex.org/C82381507","wikidata":"https://www.wikidata.org/wiki/Q416878","display_name":"Polymerase","level":3,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6505341.v1","doi":"https://doi.org/10.1158/0008-5472.c.6505341.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6505341.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6505341.v1","doi":"https://doi.org/10.1158/0008-5472.c.6505341.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.c.6505341.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2060534647","https://openalex.org/W2502897314","https://openalex.org/W2060385539","https://openalex.org/W2744992555","https://openalex.org/W2979196334","https://openalex.org/W2349674900","https://openalex.org/W2362621547","https://openalex.org/W2119585782","https://openalex.org/W2073235168","https://openalex.org/W1989978689"],"abstract_inverted_index":{"Abstract":[0],"Non\u2013small":[1],"cell":[2,70],"lung":[3],"carcinoma":[4],"patients":[5],"are":[6],"frequently":[7],"treated":[8],"with":[9],"cisplatin":[10],"(CDDP),":[11],"most":[12],"often":[13],"yielding":[14],"temporary":[15],"clinical":[16],"responses.":[17],"Here,":[18],"we":[19],"show":[20],"that":[21,67],"PARP1":[22,107],"is":[23],"highly":[24],"expressed":[25],"and":[26,85,101],"constitutively":[27],"hyperactivated":[28],"in":[29,99,102],"a":[30,63,111,120],"majority":[31,112],"of":[32,37,46,75,79,90,113],"human":[33],"CDDP-resistant":[34,114],"cancer":[35,115],"cells":[36,84,116],"distinct":[38],"histologic":[39],"origin.":[40],"Cells":[41],"manifesting":[42],"elevated":[43,88],"intracellular":[44],"levels":[45,89],"poly(ADP-ribosyl)ated":[47],"proteins":[48],"(PARhigh)":[49],"responded":[50],"to":[51,58,96,118,122,126],"pharmacologic":[52],"PARP":[53,97,127],"inhibitors":[54,98],"as":[55,57],"well":[56],"PARP1-targeting":[59],"siRNAs":[60],"by":[61],"initiating":[62],"DNA":[64],"damage":[65],"response":[66,95],"translated":[68],"into":[69],"death":[71],"following":[72],"the":[73,76,94],"activation":[74],"intrinsic":[77],"pathway":[78],"apoptosis.":[80,129],"Moreover,":[81],"PARP1-overexpressing":[82],"tumor":[83],"xenografts":[86],"displayed":[87],"PAR,":[91],"which":[92],"predicted":[93],"vitro":[100],"vivo":[103],"more":[104],"accurately":[105],"than":[106],"expression":[108],"itself.":[109],"Thus,":[110],"appear":[117],"develop":[119],"dependency":[121],"PARP1,":[123],"becoming":[124],"susceptible":[125],"inhibitor\u2013induced":[128],"Cancer":[130],"Res;":[131],"73(7);":[132],"2271\u201380.":[133],"\u00a92013":[134],"AACR.":[135]},"counts_by_year":[],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2024-03-13T00:00:00"}